Prudential Financial’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-99,284
Closed -$1.57M 2733
2023
Q3
$1.57M Buy
99,284
+35,200
+55% +$555K ﹤0.01% 1516
2023
Q2
$1.25M Buy
64,084
+12,706
+25% +$247K ﹤0.01% 1699
2023
Q1
$1.46M Sell
51,378
-16,410
-24% -$466K ﹤0.01% 1532
2022
Q4
$1.98M Buy
67,788
+2,410
+4% +$70.4K ﹤0.01% 1313
2022
Q3
$1.73M Sell
65,378
-5,760
-8% -$152K ﹤0.01% 1420
2022
Q2
$3.16M Sell
71,138
-48,035
-40% -$2.13M 0.01% 1127
2022
Q1
$5.9M Sell
119,173
-16,563
-12% -$820K 0.01% 905
2021
Q4
$6.91M Sell
135,736
-52,266
-28% -$2.66M 0.01% 862
2021
Q3
$10.5M Buy
188,002
+10,751
+6% +$600K 0.01% 719
2021
Q2
$7.59M Sell
177,251
-34,492
-16% -$1.48M 0.01% 871
2021
Q1
$8.84M Sell
211,743
-24,415
-10% -$1.02M 0.01% 813
2020
Q4
$11M Buy
236,158
+14,831
+7% +$691K 0.02% 704
2020
Q3
$9.4M Buy
221,327
+7,763
+4% +$330K 0.02% 684
2020
Q2
$10.2M Buy
213,564
+96,143
+82% +$4.61M 0.02% 686
2020
Q1
$5.4M Sell
117,421
-2,273
-2% -$105K 0.01% 887
2019
Q4
$7.19M Buy
119,694
+29,914
+33% +$1.8M 0.01% 977
2019
Q3
$5.08M Buy
89,780
+31,257
+53% +$1.77M 0.01% 1105
2019
Q2
$3.26M Buy
58,523
+3,817
+7% +$212K 0.01% 1350
2019
Q1
$2.76M Buy
54,706
+21,809
+66% +$1.1M ﹤0.01% 1433
2018
Q4
$1.33M Buy
32,897
+7,605
+30% +$307K ﹤0.01% 1713
2018
Q3
$1.75M Buy
25,292
+8,404
+50% +$583K ﹤0.01% 1671
2018
Q2
$1.28M Sell
16,888
-178,994
-91% -$13.5M ﹤0.01% 1834
2018
Q1
$10.3M Sell
195,882
-206,240
-51% -$10.9M 0.02% 894
2017
Q4
$21.5M Buy
402,122
+180,050
+81% +$9.62M 0.03% 609
2017
Q3
$13.2M Buy
222,072
+197,634
+809% +$11.8M 0.02% 784
2017
Q2
$1.93M Sell
24,438
-836
-3% -$66K ﹤0.01% 1580
2017
Q1
$2.1M Buy
25,274
+9,330
+59% +$774K ﹤0.01% 1542
2016
Q4
$1.27M Buy
15,944
+1,304
+9% +$103K ﹤0.01% 1750
2016
Q3
$1.03M Buy
+14,640
New +$1.03M ﹤0.01% 1784
2016
Q1
Sell
-31,870
Closed -$2.83M 2331
2015
Q4
$2.83M Buy
+31,870
New +$2.83M 0.01% 1347